Abstract
Serological detection of isolated anti-hepatitis B core antibody (anti-HBc) can occur in various scenarios, but the most clinically relevant situation is occult hepatitis B virus (HBV) infection (OBI). The purpose of this study was to evaluate the prevalence and clinical relevance of isolated anti-HBc and of OBI with isolated anti-HBc from an unselected hospital population. A total of 14,253 patients referred for hepatitis B surface antigen (HBsAg)/anti-HBs testing were classified into either the Health Promotion Center (HPC) group or the patient group. For patients who were negative for both HBsAg and anti-HBs, an anti-HBc test was additionally performed. An HBV DNA real-time PCR test was performed on isolated anti-HBc patients, and their demographic and clinical data were reviewed. The measured prevalence of isolated anti-HBc and OBI in isolated anti-HBc patients was 5.9 % and 4.7 %, respectively. Prevalence was higher in males, elderly people, and the patient group than in females, the younger, and the HPC group, respectively. In most cases, the levels of HBV DNA load were very low (less than 200 IU/mL), and most cases of OBI presented without liver disease or history of HBV infection. The prevalence of isolated anti-HBc and OBI are affected by the methods of detection, subject population, and constituent factors such as sex and age. Although detection of HBV DNA does not always indicate infectivity, highly sensitive standardized HBV DNA tests are needed in clinical settings to exclude the possibility of OBI, especially in the advanced age group.
Similar content being viewed by others
References
Vitale F, Tramuto F, Orlando A, Vizzini G, Meli V, Cerame G, Mazzucco W, Virdone R, Palazzo U, Villafrate MR, Tagger A, Romano N (2008) Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection? J Med Virol 80:577–582
Pondé RA, Cardoso DD, Ferro MO (2010) The underlying mechanisms for the ‘anti-HBc alone’ serological profile. Arch Virol 155:149–158
Kang SY, Kim MH, Lee WI (2010) The prevalence of “anti-HBc alone” and HBV DNA detection among anti-HBc alone in Korea. J Med Virol 82:1508–1514
Grob P, Jilg W, Bornhak H, Gerken G, Gerlich W, Günther S, Hess G, Hüdig H, Kitchen A, Margolis H, Michel G, Trepo C, Will H, Zanetti A, Mushahwar I (2000) Serological pattern “anti-HBc alone”: report on a workshop. J Med Virol 62:450–455
Gibney KB, Torresi J, Lemoh C, Biggs BA (2008) Isolated core antibody hepatitis B in sub-Saharan African immigrants. J Med Virol 80:1565–1569
Knöll A, Hartmann A, Hamoshi H, Weislmaier K, Jilg W (2006) Serological pattern “anti-HBc alone”: characterization of 552 individuals and clinical significance. World J Gastroenterol 12:1255–1260
Candotti D, Lin CK, Belkhiri D, Sakuldamrongpanich T, Biswas S, Lin S, Teo D, Ayob Y, Allain JP (2012) Occult hepatitis B infection in blood donors from South East Asia: molecular characterization and potential mechanisms of occurrence. Gut 61:1744–1753
Said ZN (2011) An overview of occult hepatitis B virus infection. World J Gastroenterol 17:1927–1938
Samal J, Kandpal M, Vivekanandan P (2012) Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev 25:142–163
Song EY, Yun YM, Park MH, Seo DH (2009) Prevalence of occult hepatitis B virus infection in a general adult population in Korea. Intervirology 52:57–62
Hochberger S, Althof D, Gallegos de Schrott R, Nachbaur N, Röck H, Leying H (2006) Fully automated quantification of hepatitis B virus (HBV) DNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system. J Clin Virol 35:373–380
Yuan Q, Ou SH, Chen CR, Ge SX, Pei B, Chen QR, Yan Q, Lin YC, Ni HY, Huang CH, Yeo AE, Shih JW, Zhang J, Xia NS (2010) Molecular characteristics of occult hepatitis B virus from blood donors in southeast China. J Clin Microbiol 48:357–362
Hollinger FB (2008) Hepatitis B virus infection and transfusion medicine: science and the occult. Transfusion 48:1001–1026
Zheng X, Ye X, Zhang L, Wang W, Shuai L, Wang A, Zeng J, Candotti D, Allain JP, Li C (2011) Characterization of occult hepatitis B virus infection from blood donors in China. J Clin Microbiol 49:1730–1737
Yuen MF, Wong DK, Lee CK, Tanaka Y, Allain JP, Fung J, Leung J, Lin CK, Sugiyama M, Sugauchi F, Mizokami M, Lai CL (2011) Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection. Clin Infect Dis 52:624–632
Phikulsod S, Oota S, Tirawatnapong T, Sakuldamrongpanich T, Chalermchan W, Louisirirotchanakul S, Tanprasert S, Chongkolwatana V, Kitpoka P, Phanuphak P, Wasi C, Nuchprayoon C, Working Group for NAT Study in Thai Blood Donations (2009) One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations. Transfusion 49:1126–1135
Launay O, Masurel J, Servant-Delmas A, Basse-Guérineau AL, Méritet JF, Laperche S, Sogni P, Rosenberg AR (2011) High levels of serum hepatitis B virus DNA in patients with ‘anti-HBc alone’: role of HBsAg mutants. J Viral Hepat 18:721–729
European Association for the Study of the Liver (2012) EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. Hepatol 57:167–185
Inaba S, Ito A, Miyata Y, Ishii H, Kajimoto S, Tanaka M, Maruta A, Saito S, Yugi H, Hino M, Tadokoro K (2006) Individual nucleic amplification technology does not prevent all hepatitis B virus transmission by blood transfusion. Transfusion 46:2028–2029
Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, Tadokoro K (2007) Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Transfusion 47:1197–1205
Candotti D, Allain JP (2009) Transfusion-transmitted hepatitis B virus infection. J Hepatol 51:798–809
Urbani S, Fagnoni F, Missale G, Franchini M (2010) The role of anti-core antibody response in the detection of occult hepatitis B virus infection. Clin Chem Lab Med 48:23–29
Acknowledgments
This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2011-0008983).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kang, SY., Kim, MH. & Lee, WI. Occult hepatitis B virus infection in Korean patients with isolated anti-HBc. Arch Virol 159, 227–233 (2014). https://doi.org/10.1007/s00705-013-1810-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-013-1810-8